MONTALTO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 30.595
EU - Europa 19.780
AS - Asia 13.143
SA - Sud America 2.004
AF - Africa 424
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 22
Totale 66.028
Nazione #
US - Stati Uniti d'America 30.258
IT - Italia 6.752
SG - Singapore 4.744
RU - Federazione Russa 4.162
CN - Cina 3.511
FI - Finlandia 1.757
BR - Brasile 1.589
DE - Germania 1.414
UA - Ucraina 1.383
VN - Vietnam 1.296
HK - Hong Kong 1.287
PL - Polonia 880
FR - Francia 741
IE - Irlanda 714
GB - Regno Unito 709
JP - Giappone 478
SE - Svezia 394
KR - Corea 306
IN - India 282
BD - Bangladesh 258
NL - Olanda 229
TR - Turchia 161
CA - Canada 140
RO - Romania 130
AR - Argentina 129
BE - Belgio 128
MX - Messico 118
IQ - Iraq 112
CI - Costa d'Avorio 104
UZ - Uzbekistan 85
ES - Italia 82
AT - Austria 78
ZA - Sudafrica 76
PK - Pakistan 72
VE - Venezuela 70
IR - Iran 68
ID - Indonesia 60
MA - Marocco 54
EC - Ecuador 53
CO - Colombia 49
EG - Egitto 48
AU - Australia 46
MY - Malesia 43
PH - Filippine 41
KE - Kenya 39
AE - Emirati Arabi Uniti 37
SA - Arabia Saudita 37
CL - Cile 36
CH - Svizzera 34
GR - Grecia 32
LB - Libano 32
DZ - Algeria 31
NP - Nepal 30
TH - Thailandia 28
AZ - Azerbaigian 25
JO - Giordania 24
BG - Bulgaria 23
PY - Paraguay 23
TN - Tunisia 23
CZ - Repubblica Ceca 22
LT - Lituania 21
IL - Israele 20
PE - Perù 20
KZ - Kazakistan 18
RS - Serbia 18
AL - Albania 16
BO - Bolivia 16
DO - Repubblica Dominicana 16
UY - Uruguay 16
NZ - Nuova Zelanda 14
HN - Honduras 13
JM - Giamaica 13
ET - Etiopia 12
TW - Taiwan 12
EU - Europa 11
OM - Oman 11
CR - Costa Rica 10
PS - Palestinian Territory 10
SN - Senegal 9
KG - Kirghizistan 8
DK - Danimarca 7
GE - Georgia 7
PA - Panama 7
PT - Portogallo 7
BH - Bahrain 6
EE - Estonia 6
HU - Ungheria 6
KH - Cambogia 6
SY - Repubblica araba siriana 6
GT - Guatemala 5
HR - Croazia 5
LU - Lussemburgo 5
NI - Nicaragua 5
NO - Norvegia 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BY - Bielorussia 4
MD - Moldavia 4
Totale 65.960
Città #
Ashburn 3.701
Fairfield 3.540
Singapore 3.128
Chandler 1.965
Woodbridge 1.731
Houston 1.601
Wilmington 1.555
San Jose 1.506
Seattle 1.360
Hong Kong 1.243
Cambridge 1.209
Ann Arbor 1.176
Zgierz 773
Dublin 709
Moscow 704
Jacksonville 691
Medford 618
Des Moines 562
Beijing 558
Palermo 516
Tokyo 457
Ho Chi Minh City 442
Milan 439
Nanjing 424
New York 400
Santa Clara 399
Princeton 394
Altamura 392
Frankfurt am Main 378
Los Angeles 363
Dallas 357
Lauterbourg 348
Rome 300
Hanoi 295
Council Bluffs 291
Dearborn 286
Lawrence 268
San Diego 237
The Dalles 229
Helsinki 205
Tulsa 202
Boardman 198
Nanchang 158
Buffalo 155
São Paulo 155
Naples 153
Shenyang 153
Jinan 140
Changsha 138
Hefei 134
Hebei 133
Chicago 124
Brussels 118
Orem 114
Tianjin 114
Abidjan 104
London 98
Columbus 91
Munich 89
Falls Church 79
Ludwigshafen am Rhein 78
Nuremberg 78
Jiaxing 77
Da Nang 76
Amsterdam 74
Verona 73
Seongnam 71
Florence 69
Venice 68
Ningbo 66
Guangzhou 65
Phoenix 62
Bologna 61
Redwood City 60
Tashkent 58
Zhengzhou 58
Saint Petersburg 57
Warsaw 56
San Paolo di Civitate 54
Turin 53
Izmir 52
Chennai 50
Denver 49
Hangzhou 49
Brooklyn 48
Johannesburg 47
Haiphong 46
Rio de Janeiro 46
Baghdad 42
Montreal 42
Atlanta 40
Manchester 40
Shanghai 40
Paris 39
Taizhou 39
Kumar 38
Toronto 38
Bremen 37
Cagliari 37
Cardiff 37
Totale 40.570
Nome #
Nodulo epatico ipovascolare: ruolo dell’ecografia nella diagnosi di HCC 4.253
ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES 386
A phenobarbital overdose: a case report 373
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 301
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 293
Cytochrome P450 2E1 variable number tandem repeat polymorphisms and health risks: A genotype-phenotype study in cancers associated with drinking and/or smoking 279
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 273
Hepatocellular carcinoma: Comparison of two different periods at the same center 272
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 270
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review 269
Serological Pattern of Hepatitis B, C, and HIV Infections Among Immigrants in Sicily: Epidemiological Aspects and Implication on Public Health 264
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 261
A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease 253
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 253
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 251
Low-grade fever: how to distinguish organic from non-organic forms. 249
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 245
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects 244
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 242
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 242
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 241
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 240
Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients 240
Encefalopatia iponatriemica in peritonite batterica spontanea in soggetto con cirrosi epatica scompensata. 239
The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine 238
Perihepatic limph nodes and anti-viral response in chronic HCV-associated hepatitis 236
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells 235
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 234
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children 233
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 232
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 232
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 231
Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis. 230
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 230
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 230
Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection 227
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 227
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 227
Solitary necrotic nodule of the liver: different pathological findings express a different histogenesis 226
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 226
Genetic determined down regulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 224
Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-a, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma 223
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 222
Serum low density lipoprotein subclasses in asthma 220
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 219
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 219
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 219
Abnormal liver function in brucellosis 218
CYP2E1 VNTR polymorphisms and hepatocarcinoma: a gender-specific correlation 218
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 217
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 217
Food allergy in gastroenterologic diseases: review of literature 216
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 216
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 214
Concomitant inflammatory pseudotumor of the liver and spleen 212
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 210
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 209
Basi fisiopatologiche dell'encefalopatia minima del cirrotico 208
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 208
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. 207
Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy. 206
Screening for autoantibodies to tissue transglutaminase reveals a low prevalence of celiac disease in blood donors with cryptogenic hypertransaminasemia 206
Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C 205
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 204
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. 204
Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis 204
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 202
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 202
Sex hormones and risk of liver tumor 201
Affidabilità del bright liver nella steatosi epatica in soggetti con ipertransaminasemia criptogenetica e con epatopatia da virus C 201
Interessamento epatico in corso di febbre bottonosa del Mediterraneo 201
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 201
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 201
Assessment of a qualitative serological assay to screen for allergic sensitization in elderly subjects 199
Relazione tra linfoadenopatia del legamento epatoduodenale e risposta alla terapia anti-virale in pazienti con epatite cronica HCV-correlata 199
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial 198
PREVALENCE OF LIVER DISEASES IN A POPULATION OF IMMIGRANTS IN SICILY. ANALYSIS OF DAY-HOSPITAL ADMISSIONS IN A DEPARTMENT OF MIGRATION MEDICINE 197
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 197
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 197
Percutaneous liver biopsy: A safe outpatient procedure? 197
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 197
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 197
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 196
Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis 196
Il bright liver echopattern come strumento diagnostico non invasivo di steatosi nell'ipertransaminasemia criptogenetica 195
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells 195
Association between single nucleotide polymorphisms (SNPs) of IL-6, TNF-alpha and VEGF-A genes, and susceptibility to hepatocellular carcinoma (HCC) 194
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 194
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 194
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 193
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 193
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 193
Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study 193
DRUG INDUCED LIVER INJURIES BY TICAGRELORSTATINS INTERACTION: A CASE REPORT 193
Hepatitis C virus infection in hemodialyzed patients 192
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 192
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 191
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 191
Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment 190
Siero-prevalenza di marcatori di infezione da virus dell’epatite B, C ed HIV in una coorte di immigrati africani a Palermo, Sicilia. 190
Totale 26.334
Categoria #
all - tutte 216.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021961 0 0 0 0 0 0 0 0 0 0 413 548
2021/20224.701 241 919 135 210 174 200 194 301 591 614 274 848
2022/20236.351 641 1.110 100 604 649 923 468 501 654 102 339 260
2023/20244.007 226 519 259 383 333 608 326 268 81 344 218 442
2024/20257.522 253 620 491 790 366 300 487 454 624 743 968 1.426
2025/202621.704 1.542 695 1.220 1.694 2.108 3.246 3.223 2.446 1.840 2.958 732 0
Totale 67.655